Ex-Trump Official Backs Medicare Coverage for Wegovy, Rejects Price Negotiation
2025-01-17
STAT
A former Trump administration health official, Joe Grogan, has expressed support for the Biden proposal to have Medicare and Medicaid cover GLP-1 weight-loss drugs like Wegovy. However, Grogan disagrees with subjecting Wegovy to price controls, citing concerns over the impact on pharmaceutical innovation and accessibility of obesity treatment. This debate highlights the ongoing discussion around healthcare policy, medication coverage, and cost control. Key issues include prescription drug pricing, healthcare accessibility, and the role of government in regulating the pharmaceutical industry.
